The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development.
- DOI
- 10.3389/fphar.2018.01301
- Published
- 2018
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2018.01301,
title = {The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development.},
author = {Reijntjes S and Albayaty M and Bush J and Cheriyan J and Cromie A and Koch A and Hammond M and Mair S and Scholes P and Lorch U and Stringer S and Taubel J and Hardman TC},
year = {2018},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2018.01301},
url = {https://doi.org/10.3389/fphar.2018.01301}
}RIS
TY - JOUR TI - The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development. AU - Reijntjes S AU - Albayaty M AU - Bush J AU - Cheriyan J AU - Cromie A AU - Koch A AU - Hammond M AU - Mair S AU - Scholes P AU - Lorch U AU - Stringer S AU - Taubel J AU - Hardman TC PY - 2018 JO - Frontiers in pharmacology DO - 10.3389/fphar.2018.01301 UR - https://doi.org/10.3389/fphar.2018.01301 ER -
APA
S, R., M, A., J, B., J, C., A, C., A, K., M, H., S, M., P, S., U, L., S, S., J, T., & TC, H. (2018). The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2018.01301
Source records
- pubmed · retrieved 2026-09-25T05:43:39.142Z